Mesothelin Expression in Gastric Adenocarcinoma and Its Relation to Clinical Outcomes

about

Amatuximab and novel agents targeting mesothelin for solid tumors.

P2860

Q47126660-D58BFC85-B884-44AB-99FB-B5E3432174FC

P2860

Mesothelin Expression in Gastric Adenocarcinoma and Its Relation to Clinical Outcomes

Item

http://www.wikidata.org/entity/Q41992584

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Mesothelin Expression in Gastric Adenocarcinoma and Its Relation to Clinical Outcomes

@en

type

Item

label

Mesothelin Expression in Gastric Adenocarcinoma and Its Relation to Clinical Outcomes

@en

prefLabel

Mesothelin Expression in Gastric Adenocarcinoma and Its Relation to Clinical Outcomes

@en

P1476

Mesothelin Expression in Gastric Adenocarcinoma and Its Relation to Clinical Outcomes

@en

P2093

Hanseong Kim

http://www.w3.org/2001/XMLSchema#string

Mee Joo

http://www.w3.org/2001/XMLSchema#string

Song-Hee Han

http://www.w3.org/2001/XMLSchema#string

Sunhee Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers

Mesothelin-induced pancreatic cancer cell proliferation involves alteration of cyclin E via activation of signal transducer and activator of transcription protein 3

Mesothelin targeted cancer immunotherapy

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis.

Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data.

Diffuse mesothelin expression correlates with prolonged patient survival in ovarian serous carcinoma.

Wilms' tumor 1 (WT1) expression and prognosis in solid cancer patients: a systematic review and meta-analysis.

P304

122-128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4132/JPTM.2016.11.18

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28196410

http://www.w3.org/2001/XMLSchema#string

P932

5357757

http://www.w3.org/2001/XMLSchema#string

Mesothelin Expression in Gastric Adenocarcinoma and Its Relation to Clinical Outcomes

about

P2860

P2860

Mesothelin Expression in Gastric Adenocarcinoma and Its Relation to Clinical Outcomes

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932